Functional Massage Versus Passive Mobilization After Total Knee Replacement
Functional Recovery in the Acute Phase After Total Knee Arthroplasty: A Randomized Controlled Trial Comparing Two Different Physiotherapy Protocols
This study compares two physiotherapy treatments to help adults recover movement after total knee replacement: functional massage and passive knee mobilization. The main question is whether functional massage helps patients bend their knee further by the time they leave the acute hospital ward.
Forty adults undergoing replacement of one knee or both knees during the same operation will be randomly assigned to one of two groups. One group will receive functional massage according to Olaf Evjenth, and the other will receive passive manual knee mobilization. Both groups will also receive the same standard rehabilitation and pain management.
The assigned treatment will be provided once daily, starting on the first day after surgery and continuing until hospital discharge. Each treatment will last 10 minutes per operated knee.
A clinician who does not know which treatment the patient received will assess knee movement. The study will also evaluate pain, functional mobility, patient-reported outcomes, and length of hospital stay.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
This is a single-center, randomized, parallel-group superiority trial comparing two manual physiotherapy approaches during the acute phase after total knee arthroplasty.
An independent researcher will generate the random allocation sequence. Allocation will be concealed using sequentially numbered, opaque, sealed envelopes, opened after eligibility has been confirmed and written informed consent obtained.
The primary analysis will follow the intention-to-treat principle. Passive knee flexion at discharge will be compared between groups using analysis of covariance, with baseline knee flexion as a covariate. For participants undergoing simultaneous bilateral total knee arthroplasty, one knee will be randomly selected for the primary analysis. A sensitivity analysis using mixed-effects models will account for paired knee measurements. Exploratory analyses will compare treatment effects in participants undergoing unilateral and simultaneous bilateral surgery.
Discharge timing depends on the availability of a bed in an inpatient rehabilitation facility rather than on predefined functional recovery thresholds.
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Simone Patuzzo, Physiotherapist
- Telefonnummer: +393408117670
- E-post: simone.patuzzo@aovr.veneto.it
Studiesteder
-
-
Verona
-
Verona, Verona, Italia, 37126
- Azienda Ospedaliera Universitaria Integrata Verona - U.O.C. Ortopedia, Ospedale Chirurgico Confortini
-
Ta kontakt med:
- Simone Patuzzo
- Telefonnummer: +393408117670
- E-post: simone.patuzzo@aovr.veneto.it
-
Ta kontakt med:
- Daniela Isolani
- Telefonnummer: 00390458122480
- E-post: daniela.isolani@intra.aovr.veneto.it
-
Hovedetterforsker:
- Simone Patuzzo
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Male and female patients aged 18 to 79 years.
- Scheduled for elective primary total knee arthroplasty, either unilateral or simultaneous bilateral.
- Ability to understand the nature of the study and provide written informed consent.
Exclusion Criteria:
- Revision total knee arthroplasty.
- Age 80 years or older.
- Severe comorbidities that could interfere with participation in the rehabilitation protocol or outcome assessment, including severe heart failure, severe chronic obstructive pulmonary disease, severe obesity with body mass index greater than 40 kg/m², or neurological conditions with significant motor deficits.
- Cognitive deficits that prevent understanding and signing the informed consent or active participation in rehabilitation.
- Total knee arthroplasty performed for non-degenerative causes, such as acute trauma or tumors.
- Concomitant participation in another interventional clinical trial.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Eksperimentell: Functional Massage
Participants receive functional massage according to Olaf Evjenth once daily from postoperative day 1 until hospital discharge, together with standardized pain management, assisted walking, and strengthening exercises. |
Functional massage of the anterior thigh with passive or active-assisted knee flexion, performed with the patient seated. Treatment lasts 10 minutes per operated knee, once daily, from postoperative day 1 until hospital discharge. |
|
Aktiv komparator: Passive Manual Mobilization
Participants receive passive manual knee mobilization once daily from postoperative day 1 until hospital discharge, together with standardized pain management, assisted walking, and strengthening exercises. |
Passive manual knee flexion and extension in the sagittal plane, performed with the patient supine. Treatment lasts 10 minutes per operated knee, once daily, from postoperative day 1 until hospital discharge. |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Knee Flexion
Tidsramme: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
|
Passive knee flexion is measured in degrees using a standard goniometer, with the assessor moving the knee. Measurements are collected daily from postoperative day 1 until hospital discharge |
Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain Intensity
Tidsramme: At baseline and daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
|
Pain intensity is assessed using a Visual Analogue Scale and recorded on a 0-10 scale, with higher scores indicating greater pain. Measurements are collected at baseline and daily after each rehabilitation session from postoperative day 1 until hospital discharge, including the discharge day. Each daily measurement is recorded separately. |
At baseline and daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
|
|
Timed Up and Go Test
Tidsramme: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
|
Time in seconds required to stand up, walk 3 meters, turn, walk back, and sit down. The test is performed daily after the rehabilitation session from postoperative day 1 until hospital discharge, including the discharge day. Shorter times indicate better functional mobility. Each daily measurement is recorded separately. |
Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
|
|
Length of Hospital Stay
Tidsramme: At discharge from the acute hospital ward, typically 5-7 days after surgery.
|
Number of days from admission to the acute hospital ward until discharge |
At discharge from the acute hospital ward, typically 5-7 days after surgery.
|
|
Oxford Knee Score on Postoperative Day 1
Tidsramme: Postoperative day 1.
|
The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. |
Postoperative day 1.
|
|
Oxford Knee Score at Hospital Discharge
Tidsramme: At discharge from the acute hospital ward, typically 5-7 days after surgery.
|
The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. |
At discharge from the acute hospital ward, typically 5-7 days after surgery.
|
|
Oxford Knee Score at 1 Month
Tidsramme: 1 month after surgery
|
The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. The questionnaire is administered by telephone interview. |
1 month after surgery
|
|
Oxford Knee Score at 3 Months
Tidsramme: 3 months after surgery
|
The Oxford Knee Score is a 12-item questionnaire assessing knee pain and difficulties with everyday activities over the previous four weeks. Each item is scored from 0 to 4. The total score ranges from 0 to 48, with higher scores indicating less pain and better function. The questionnaire is administered by telephone interview. |
3 months after surgery
|
|
EQ-5D-5L Utility Index at day 1
Tidsramme: Postoperative day 1.
|
The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life |
Postoperative day 1.
|
|
EQ-5D-5L Utility Index at discharge
Tidsramme: At discharge from the acute hospital ward, typically 5-7 days after surgery.
|
The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life. |
At discharge from the acute hospital ward, typically 5-7 days after surgery.
|
|
EQ-5D-5L Utility Index at 1 Month
Tidsramme: 1 month after surgery
|
The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life. The questionnaire is administered by telephone |
1 month after surgery
|
|
EQ-5D-5L Utility Index at 3 Months
Tidsramme: 3 months after surgery
|
The EQ-5D-5L assesses five dimensions of health: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five response levels, from no problems to extreme problems or inability to perform the activity. Responses are converted into a health utility index using a country-specific value set. Higher index values indicate better health-related quality of life. The questionnaire is administered by telephone |
3 months after surgery
|
|
EQ VAS on Postoperative Day 1
Tidsramme: On postoperative day 1.
|
Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health. |
On postoperative day 1.
|
|
EQ VAS at Hospital Discharge
Tidsramme: At hospital discharge, typically 5-7 days after surgery.
|
Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health. |
At hospital discharge, typically 5-7 days after surgery.
|
|
EQ VAS at 1 Month
Tidsramme: At 1 month after surgery.
|
Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health.The assessment is administered by telephone |
At 1 month after surgery.
|
|
EQ VAS at 3 Months
Tidsramme: At 3 months after surgery.
|
Participants rate their overall health today on a scale from 0 (the worst health they can imagine) to 100 (the best health they can imagine). Higher scores indicate better self-rated health. The assessment is administered by telephone |
At 3 months after surgery.
|
Andre resultatmål
Andre resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Walking Distance During Assisted Ambulation
Tidsramme: Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
|
Distance walked during assisted ambulation, measured in meters and recorded daily after the rehabilitation session. |
Daily from postoperative day 1 until hospital discharge, typically 5-7 days after surgery.
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Hovedetterforsker: Simone Patuzzo, Azienda Ospedaliera Universitaria Integrata Verona
Studierekorddatoer
Studer hoveddatoer
Studiestart (Antatt)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
Andre studie-ID-numre
- TKA-PATUZZO-2025-01
- 1000CET (Annen identifikator: Comitato Etico Territoriale Area Sud-Ovest Veneto (CET-ASOV))
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .